Shanghai Fudan-Zhangjiang Bio-PharmaceuticalLtd Dividend
Dividend criteria checks 2/6
Shanghai Fudan-Zhangjiang Bio-PharmaceuticalLtd is a dividend paying company with a current yield of 3.57% that is well covered by earnings. Next payment date is on 26th August, 2024 with an ex-dividend date of 4th July, 2024.
Key information
3.6%
Dividend yield
67%
Payout ratio
| Industry average yield | 3.7% |
| Next dividend pay date | 26 Aug 24 |
| Ex dividend date | 04 Jul 24 |
| Dividend per share | n/a |
| Earnings per share | HK$0.10 |
| Dividend yield forecast in 3Y | n/a |
Recent dividend updates
Recent updates
What To Know Before Buying Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co., Ltd. (HKG:1349) For Its Dividend
Apr 12
We Think Shanghai Fudan-Zhangjiang Bio-Pharmaceutical (HKG:1349) Can Manage Its Debt With Ease
Mar 22Should You Be Adding Shanghai Fudan-Zhangjiang Bio-Pharmaceutical (HKG:1349) To Your Watchlist Today?
Mar 07Are Strong Financial Prospects The Force That Is Driving The Momentum In Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co., Ltd.'s HKG:1349) Stock?
Feb 20Could The Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co., Ltd. (HKG:1349) Ownership Structure Tell Us Something Useful?
Feb 07Should Shanghai Fudan-Zhangjiang Bio-Pharmaceutical (HKG:1349) Be Disappointed With Their 38% Profit?
Jan 25Should You Rely On Shanghai Fudan-Zhangjiang Bio-Pharmaceutical's (HKG:1349) Earnings Growth?
Jan 12Would Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co., Ltd. (HKG:1349) Be Valuable To Income Investors?
Dec 28Shanghai Fudan-Zhangjiang Bio-Pharmaceutical (HKG:1349) Seems To Use Debt Rather Sparingly
Dec 15Should You Be Adding Shanghai Fudan-Zhangjiang Bio-Pharmaceutical (HKG:1349) To Your Watchlist Today?
Dec 03Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co., Ltd.'s (HKG:1349) Fundamentals Look Pretty Strong: Could The Market Be Wrong About The Stock?
Nov 21Upcoming Dividend Payment
Stability and Growth of Payments
Fetching dividends data
Stable Dividend: 1349 has been paying a dividend for less than 10 years and during this time payments have been volatile.
Growing Dividend: 1349's dividend payments have increased, but the company has only paid a dividend for 9 years.
Dividend Yield vs Market
| Shanghai Fudan-Zhangjiang Bio-PharmaceuticalLtd Dividend Yield vs Market |
|---|
| Segment | Dividend Yield |
|---|---|
| Company (1349) | 3.6% |
| Market Bottom 25% (HK) | 3.4% |
| Market Top 25% (HK) | 8.3% |
| Industry Average (Pharmaceuticals) | 3.7% |
| Analyst forecast in 3 Years (1349) | n/a |
Notable Dividend: 1349's dividend (3.57%) is higher than the bottom 25% of dividend payers in the Hong Kong market (3.45%).
High Dividend: 1349's dividend (3.57%) is low compared to the top 25% of dividend payers in the Hong Kong market (8.26%).
Earnings Payout to Shareholders
Earnings Coverage: With its reasonable payout ratio (66.6%), 1349's dividend payments are covered by earnings.
Cash Payout to Shareholders
Cash Flow Coverage: 1349 is paying a dividend but the company has no free cash flows.